Anti-diabetic properties of chromium citrate complex in alloxan-induced diabetic rats

Journal of Trace Elements in Medicine and Biology

Volumn 25, Issue 4, 2011, Pages 218-224

  Li, Fang ^a   Wu, Xiangyang ^a   Zhao, Ting ^a   Zhang, Min ^a   Zhao, Jiangli ^a   Mao, Guanghua ^a   Yang, Liuqing ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Acute oral toxicity; Anti diabetic activity; Chromium citrate complex; Oxidative DNA damage

Indexed keywords

ALLOXAN; CHROMIUM; CHROMIUM CITRATE COMPLEX; CHROMIUM DERIVATIVE; CHROMIUM TRICHLORIDE HEXAHYDYRATE; CITRIC ACID; EDETATE IRON; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; DRUG DOSE COMPARISON; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; INFRARED SPECTROSCOPY; LD 50; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THERMODYNAMICS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET SPECTROSCOPY; ULTRAVIOLET VISIBLE SPECTROSCOPY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CHROMIUM; CITRATES; COORDINATION COMPLEXES; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; FEMALE; GLYCOGEN; HYPOGLYCEMIC AGENTS; LIVER; MALE; OXIDATIVE STRESS; RATS; TOXICITY TESTS; TRIGLYCERIDES;

RATTUS;

EID: 82855178729     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.08.143     Document Type: Article

References (35)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Ghosh D., Bhattacharya B., Mukherjee B., Manna B., Sinha M., Chowdhury J., et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutrl Biochem 2002, 13:690-697.
3. Kim D.S., Kim T.W., Kang J.S. Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem Med Biol 2004, 17:243-247.
4. Shara M., Yasmin T., Kincaid A.E., Limpach A.L., Bartz J., Brenneman K.A., et al. Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex. J Nutrl Biochem 2005, 99:2161-2183.
5. Anderson R.A. Chromium and insulin resistance. Nutr Res Rev 2003, 16:267-275.
6. Vincent J.B., Sun Y.J., Clodfelder B.J. Biomimetic chromium complex enhances insulin sensitivity in healthy and type II diabetic model rats. Diabetes 2001, 50:A508-A518.
7. Vincent J.B., Bennett R. The Nutritional Biochemistry of Chromium(III) 2007, Elsevier, Amsterdam, p. 139-60.
8. 3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Lett 2005, 579:1458-1464.
9. Dogukan A., Tuzcu M., Juturu V., Cikim G., Ozercan I., Komorowski J., et al. Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats. J Renal Nutr 2010, 20:112-120.
10. Jennings D.S., Brevard P.B., Flohr J.A., Gloeckner J.W. Chromium nicotinate supplementation: effects on body composition and strength in female colleigate athletes participating in off-season training. J Am Diet Assoc 1997, 97. A65-A65.
11. 3. J Inorg Biochem 2006, 100:1187-1193.
12. Vrtovec M., Vrtovec B., Briski A., Kocijancic A., Anderson R.A., Radovancevic B. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am Heart J 2005, 149:632-636.
13. Besong S., Jackson J.A., Trammell D.S., Akay V. Influence of supplemental chromium on concentrations of liver triglyceride, blood metabolites and rumen VFA profile in steers fed a moderately high fat diet. J Dairy Sci 2001, 84:1679-1685.
14. Stallings D.M., Hepburn D.D.D., Hannah M., Vincent J.B., O'Donnell J. Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster. Mut Res/Genet Toxicol Environ Mutagen 2006, 610:101-113.
15. Hepburn D.D.D., Vincent J.B. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem 2003, 94:86-93.
16. Wu X.Y., Li F., Xu W.D., Zhao J.L., Zhao T., Liang L.H., et al. Anti-hyperglycemic activity of chromium(III) malate complex in alloxan-induced diabetic rats. Biolog Trace Elem Res 2010, 10.1007/s12011-010-8916-6.
17. Król E., Krejpcio Z. Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem Toxicol 2010, 48:2791-2796.
18. Staniek H., Kostrzewska-Poczekaj M., Arndt M., Szyfter K., Krejpcio Z. Genotoxicity assessment of chromium(III) propionate complex in the rat model using the comet assay. Food Chem Toxicol 2010, 48:89-92.
19. Staniek H., Krejpcio Z., Iwanik K. Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat. Food Chem Toxicol 2010, 48:859-864.
20. Suzuki A., Sarangbin S., Kirimura K., Usami S. Direct production of citric acid from starch by a 2-deoxyglucose-resistant mutant strain of Aspergillus niger. J Fermen Bioeng 1996, 81:320-323.
21. Xie M-j, Yang X-D., Liu W-p, Yan S-p, Meng Z-h. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity. J Inorg Biochem 2010, 104:851-857.
22. Buccolo G., David M. Quantitative determination of serum triglycerides by use of enzyme. Clin Chem 1973, 19:476-482.
23. Carroll N.V., Longly R.W., Joseph H.R. Determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 1956, 220:583-593.
24. Hallwell B., Gutteridge M.C., Aruoma O.I. The deoxyribose method: a simple test-tube assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 1987, 165:215-219.
25. Hilaly J.E., Israili Z.H., Lyoussi B. Acute and chronic toxicological studies of Ajuga iva in experimental animals. J Ethnopharmacol 2004, 91:43-50.
26. Kameswara Rao B., Kesavulu M.M., Giri R., Appa Rao C. Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. fruit powder in alloxan-diabetic rats. J Ethnopharmacol 1999, 67:103-109.
27. Yanardag R., Demirci T.B., ülküseven B., Bolkent S., Tunali S., Bolkent S. Synthesis, characterization and antidiabetic properties of N1-2,4-dihydroxybenzylidene-N4-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV). Eur J Med Chem 2009, 44:818-826.
28. Shinde U.A., Sharma G., Xu Y.J., Dhalla N.S., Goyal R.K. Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus. J Trace Elem Med Bio 2004, 18:23-32.
29. Ferrannini E., Lanfranchi A., Rohner-Jeanrenaud F., Manfredini G., Van de Werve G. Influence of long-term diabetes on liver glycogen metabolism in the rat. Metabolism 1990, 39:1082-1088.
30. Hems D.A., Harmon C.S., Whitton P.D. Inhibition by parathyroid hormone of glycogen synthesis in the perfused rat liver. FEBS Lett 1975, 58:167-169.
31. Weber G., Hird Convery H.J. Insulin: inducer of glucose 6-phosphate dehydrogenase. Life Sci 1966, 5:1139-1146.
32. Ajikumaran Nair S., Shylesh B.S., Gopakumar B., Subramoniam A. Anti-diabetes and hypoglycaemic properties of Hemionitis arifolia (Burm.) Moore in rats. J Ethnopharmacol 2006, 106:192-197.
33. European Union, Council Directive 92/32/EEC of 30 April 1992 amending for the Seventh Time Directive 67/548/EEC on the approximation of the laws. Regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=CELEX%3A31992L0032%3AEN%3AHTM.
34. ATSDR. Draft Toxicological Profile for Chromium. US Department of Health and Human Services Public Health Service. Agency for toxic substances and disease registry 2008. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp7.pdf.
35. Zhou Z.-C. A course in toxicology 2006, Peking University Publishing House, Beijing, p. 266-70.